Keyword: Ranbaxy Laboratories
News
09.04.2014
- Sun Pharmaceutical Industries, India's largest drugmaker by market value, has agreed to buy compatriot generics manufacturer Ranbaxy Laboratories for $3.2 billion from Daiichi...
News
27.01.2014
- Indian drugmaker Ranbaxy Laboratories faces long delays and high costs in launching big-selling generic drugs in the U.S. after products from a fourth plant were banned due to...
News
18.07.2013
- Novartis raised its full-year outlook on Wednesday after generic competition to its best-selling blood pressure pill was delayed, granting the Swiss drugmaker a temporary reprieve...
News
27.01.2011
- Ranbaxy Laboratories, India's top drugmaker, said on Thursday its chief financial officer had resigned, the third top official to quit after Japan's Daiichi Sankyo took majority...